GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Additional Paid-In Capital

Abingdon Health (LSE:ABDX) Additional Paid-In Capital : £30.31 Mil(As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health Additional Paid-In Capital?


Abingdon Health's quarterly additional paid-in capital stayed the same from Dec. 2022 (£30.31 Mil) to Jun. 2023 (£30.31 Mil) and stayed the same from Jun. 2023 (£30.31 Mil) to Dec. 2023 (£30.31 Mil).

Abingdon Health's annual additional paid-in capital increased from Jun. 2021 (£24.18 Mil) to Jun. 2022 (£30.31 Mil) but then stayed the same from Jun. 2022 (£30.31 Mil) to Jun. 2023 (£30.31 Mil).

Abingdon Health Additional Paid-In Capital Historical Data

The historical data trend for Abingdon Health's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Additional Paid-In Capital Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Additional Paid-In Capital
Get a 7-Day Free Trial 13.20 13.20 24.18 30.31 30.31

Abingdon Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.31 30.31 30.31 30.31 30.31

Abingdon Health Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Abingdon Health Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Abingdon Health (LSE:ABDX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Additional Paid-In Capital
Comparable Companies
LSE:VRCI LSE:GDR LSE:GENI LSE:PRM LSE:LLAI LSE:AGL TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX WAT EXAS
Traded in Other Exchanges
N/A
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Website
https://www.abingdonhealth.com
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines